Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Clinical Deployment Task Force

Clinical Deployment Task Force

BACK

Clinical Deployment Task Force

Mission: Promote use of in silico medicine from product development to clinical practice

The Clinical Deployment Task Force promotes the use of
in silico methods by investigating and showcasing their bench-to-bedside trajectory.

With the support of the task force members, an inventory of key
in silico methods already integrated into, or close to, clinical application will be established. These in silico clinical applications will be identified through internal consultation with the task force members and external benchmarking, to include clinical applications across of a range of fields, such as drug development and medical device testing. The identified in silico applications will then be evaluated as case examples to assess the technological hurdles encountered before successful clinical implementation. This feasibility study on the clinical and industrial valorization of these in silico applications will help to develop and optimize the envisioned frameworks of future in silico methods to facilitate their clinical translation and valorization.

The ambition of this task force is to dynamically grow the number of clinical applications, principally in the pharmaceutical and medtech industries, by actively exploring and strategically considering their readiness for clinical implementation or industrial valorization, in close consultation with task force members.

Goals

  • Create an expert group among members of Avicenna Alliance
  • Promote the use of in silico medicine by showcasing their bench-to-bedside trajectory
  • Promote use of in silico approaches in Go-to-market Strategy
  • Investigate in silico use in Clinical diagnostics (e.g., clinical decision tools, AI-powered pathology)

Erica Beaucage-Gauvreau

Erica Beaucage-Gauvreau

Co-Chair of the Clinical Deployment Task Force

Coordinator of iSi Health, the KU Leuven institute of Physics-based modeling for in silico …

READ BIO
Wen-Yang Chu

Wen-Yang Chu

Co-Chair of the Clinical Deployment Task Force

Co-founder and CTO of Virtonomy Gmbh. He has more than 10 years’ experience in MedTech industry …

READ BIO

NEWS

News The European Parliament voted the reform of General Pharmaceutical Legislation (GPL)

The European Parliament voted the reform of General Pharmaceutical Legislation (GPL)

On April 10, the European Parliament overwhelmingly backed the reform of General Pharmaceutical Legislation (GPL), marking a pivotal moment in healthcare regulation. With a resounding majority, both the Directive and Regulation were embraced, reflecting a collaborative effort within the ENVI committee.

News The Avicenna Alliance warmly welcomes Tox By Design into its esteemed ranks!

The Avicenna Alliance warmly welcomes Tox By Design into its esteemed ranks!

Tox by Design is a prominent European toxicological expertise firm specializing in conducting toxicological Risk Assessments (RAs) for various industries such as biotech, pharmaceuticals, cosmetics, medical devices, and API synthesis.

News Marc Horner is the new Avicenna International Affairs Working Group Leader

Marc Horner is the new Avicenna International Affairs Working Group Leader

We are thrilled to announce that Marc Horner, Distinguished Engineer at Ansys, and Global Harmonization Task Force leader at the Avicenna Alliance, has been appointed as the new International Affairs Working Group Leader. Marc was already acting as a close partner of Nathalie Virag, former head of the International Affairs Working Group, recently appointed by Medtronic to prestigious responsibilities.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry